anayamalik, Author at European Medical Journal - Page 2 of 96

child steroid treatment

Children Weaned Off Steroids Avoid Crises

Adrenal crisis was rare after glucocorticoid taper in children with nephrotic syndrome or juvenile idiopathic arthritis.

Cows on a dairy farm representing animal-to-human transmission risk in brucellosis treatment

Animal Exposure to Treatment Failure: Optimized Regimens in Brucellosis

Network meta-analysis ranks brucellosis treatment regimens, finding triple-drug combinations outperform widely used dual therapies.

polygenic risk scores for breast cancer concept, patient counseling

Breast Cancer Polygenic Risk Scores Awareness Lags

High-risk women had limited awareness yet strong support for breast cancer polygenic risk scores in clinical risk assessment more.

smoking risk concept

Smoking Tied to Faster Huntington’s Decline

Huntington’s disease is progressive and incurable, so modifiable factors that influence symptom onset and progression are clinically relevant.

Hospital respiratory care setup with nebulizer preparation for pneumonia treatment

Distinguishing Mycoplasma pneumoniae in Community-Acquired Pneumonia

Mycoplasma pneumoniae accounts for a meaningful share of community-acquired pneumonia in younger hospitalized adults.

Endoscope prepared for upper GI endoscopy to detect Helicobacter pylori in real time

Real Time Endoscopy Model Predicts H. pylori Accurately

A deep learning model used during EGD accurately predicts Helicobacter pylori infection showing multicenter diagnostic performance.

Woman holding pill pack

Managing Hereditary Angioedema with Normal C1 Inhibitor

Real-world evidence indicates that hereditary angioedema with normal C1 inhibitor is frequently hormone sensitive.

Machine Learning Predicts ICU Readmission After Stroke

In patients with cerebral infarction, machine learning models using neurophysiological and clinical data predicted ICU readmission.

Conceptual image showing patient well-being and cancer care evaluation in early-stage lung cancer.

Patient QoL Often Overlooked in Early-Stage NSCLC Research

Health-related quality of life remains significantly underreported in trials evaluating tyrosine kinase inhibitors and immune checkpoint inhibitors for early-stage non-small cell lung cancer.

conceptual illustration of the gut microbiome and healthy aging

Gut Microbiome Shapes Healthy Aging Trajectories

The gut microbiome emerges as a modifiable driver of healthy aging, with evidence from model organisms supporting a causal role for gut microbes in lifespan and healthspan.